TESTOSTERONE ENANTHATE

TESTOSTERONE ENANTHATE was reported 1642 times

TESTOSTERONE ENANTHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIAC VALVE FIBROELASTOMA 4 0.1026
1 GLUCOSE TOLERANCE DECREASED 4 0.0976
2 OROPHARYNGEAL COBBLE STONE MUCOSA 1 0.0714
3 PERFORMANCE ENHANCING PRODUCT USE 5 0.0505
4 FORCED EXPIRATORY VOLUME ABNORMAL 6 0.0414
5 PUNCTURE SITE REACTION 3 0.0375
6 PLATYPNOEA 1 0.0345
7 ENDOMETRIAL SARCOMA 1 0.0345
8 BILE DUCT ADENOCARCINOMA 2 0.0333
9 CEREBELLAR ARTERY OCCLUSION 1 0.0333
10 CHOLESTATIC PRURITUS 1 0.0312
11 SECONDARY HYPOGONADISM 9 0.0273
12 HEART RATE VARIABILITY DECREASED 1 0.0244
13 OVARIAN ENDOMETRIOID CARCINOMA 1 0.0238
14 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4 0.0223
15 BENIGN ABDOMINAL NEOPLASM 1 0.0208
16 BLOOD PRESSURE DIFFERENCE OF EXTREMITIES 1 0.0172
17 CEREBRAL MICROINFARCTION 1 0.0172
18 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 3 0.0170
19 BLOOD LUTEINISING HORMONE DECREASED 3 0.0168
20 NIPPLE ENLARGEMENT 1 0.0161
21 OPPOSITIONAL DEFIANT DISORDER 6 0.0152
22 LIGAMENTITIS 1 0.0139
23 ANOGENITAL DYSPLASIA 2 0.0133
24 DYSANIA 1 0.0130
25 ENDOMETRIAL CANCER STAGE III 1 0.0127
26 DELAYED SLEEP PHASE 1 0.0122
27 DOSING ERROR 2 0.0119
28 DELAYED PUBERTY 3 0.0118
29 DYSKINESIA OESOPHAGEAL 1 0.0112
30 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 4 0.0111
31 CONNECTIVE TISSUE INFLAMMATION 1 0.0105
32 PROLACTIN-PRODUCING PITUITARY TUMOUR 2 0.0102
33 LACK OF ADMINISTRATION SITE ROTATION 3 0.0098
34 ADMINISTRATION SITE HAEMORRHAGE 1 0.0096
35 HYPERTROPHIC SCAR 1 0.0092
36 CRANIOPHARYNGIOMA 3 0.0090
37 TOXIC CARDIOMYOPATHY 2 0.0089
38 AORTIC VALVE REPAIR 1 0.0089
39 INJECTION SITE ABSCESS STERILE 1 0.0088
40 PRODUCT SUBSTITUTION ERROR 1 0.0085
41 AORTIC ANEURYSM REPAIR 1 0.0084
42 PROLACTINOMA 1 0.0077
43 PERFORATION BILE DUCT 1 0.0077
44 ADMINISTRATION SITE IRRITATION 1 0.0071
45 GERM CELL CANCER 1 0.0069
46 PORTAL VEIN OCCLUSION 1 0.0068
47 BONE LESION EXCISION 1 0.0066
48 BLOOD TESTOSTERONE INCREASED 14 0.0065
49 PRIMARY HYPOGONADISM 1 0.0064
50 INJECTION SITE LACERATION 4 0.0062
51 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10 0.0062
52 CEREBRAL CONGESTION 1 0.0060
53 SUBSTANCE DEPENDENCE 4 0.0059
54 PAIN MANAGEMENT 1 0.0059
55 BREAST CANCER MALE 3 0.0059
56 POLYCYTHAEMIA 12 0.0058
57 PITUITARY APOPLEXY 1 0.0057
58 BASILAR ARTERY THROMBOSIS 1 0.0056
59 ACANTHOSIS NIGRICANS 1 0.0054
60 DEFORMITY THORAX 1 0.0052
61 ACNE FULMINANS 1 0.0051
62 BLOOD OESTROGEN INCREASED 3 0.0051
63 NAIL HYPERTROPHY 1 0.0049
64 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 1 0.0048
65 LIGHT CHAIN ANALYSIS ABNORMAL 1 0.0048
66 STUBBORNNESS 2 0.0046
67 GROWTH ACCELERATED 1 0.0046
68 FAMILIAL PERIODIC PARALYSIS 1 0.0044
69 HAEMATOCRIT INCREASED 10 0.0044
70 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
71 BREATHING-RELATED SLEEP DISORDER 1 0.0042
72 ALCOHOL PROBLEM 1 0.0041
73 EOSINOPHIL COUNT ABNORMAL 3 0.0040
74 NIPPLE SWELLING 1 0.0040
75 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
76 OBSESSIVE-COMPULSIVE PERSONALITY DISORDER 1 0.0040
77 INSULIN-LIKE GROWTH FACTOR DECREASED 2 0.0038
78 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 2 0.0037
79 LYMPHOCYTIC HYPOPHYSITIS 1 0.0036
80 CHONDROMALACIA 1 0.0035
81 MERYCISM 1 0.0035
82 TESTICULAR ATROPHY 3 0.0034
83 OESTRADIOL INCREASED 1 0.0033
84 CREATININE URINE INCREASED 1 0.0033
85 INCISION SITE SWELLING 1 0.0033
86 PARAPROTEINAEMIA 1 0.0032
87 MUSCLE TONE DISORDER 1 0.0032
88 BLOOD OSMOLARITY DECREASED 2 0.0032
89 BED REST 1 0.0032
90 LIPOSARCOMA 1 0.0031
91 COLD-STIMULUS HEADACHE 1 0.0031
92 HAEMATOLOGY TEST ABNORMAL 1 0.0031
93 NODAL OSTEOARTHRITIS 1 0.0031
94 INGUINAL HERNIA REPAIR 1 0.0030
95 HYPOGONADISM 3 0.0030
96 BLOOD TESTOSTERONE DECREASED 20 0.0029
97 ELBOW DEFORMITY 1 0.0029
98 ADMINISTRATION SITE BRUISE 1 0.0029
99 MUSCLE HYPERTROPHY 1 0.0028
100 ANDROGEN DEFICIENCY 1 0.0028
101 MULTIPLE SYSTEM ATROPHY 1 0.0028
102 HYPOTHALAMO-PITUITARY DISORDER 4 0.0027
103 APPLICATION SITE PUSTULES 1 0.0027
104 BLOOD CULTURE POSITIVE 8 0.0027
105 BODY DYSMORPHIC DISORDER 1 0.0027
106 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
107 HEARING DISABILITY 1 0.0026
108 BONE DENSITY INCREASED 1 0.0025
109 AMMONIA ABNORMAL 1 0.0025
110 DELIRIUM TREMENS 1 0.0025
111 LIBIDO INCREASED 5 0.0025
112 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
113 APPLICATION SITE LACERATION 1 0.0024
114 CONGESTIVE HEPATOPATHY 1 0.0022
115 RED BLOOD CELL COUNT INCREASED 6 0.0022
116 STREPTOCOCCAL INFECTION 12 0.0022
117 INJECTION SITE CELLULITIS 4 0.0022
118 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
119 CRANIAL NERVE PARALYSIS 1 0.0021
120 EXPOSURE VIA DIRECT CONTACT 2 0.0021
121 INSULIN-LIKE GROWTH FACTOR INCREASED 3 0.0021
122 MORPHOEA 1 0.0021
123 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
124 HEPATIC ADENOMA 1 0.0019
125 DEVICE USE CONFUSION 1 0.0019
126 INFUSION SITE VESICLES 1 0.0019
127 ALBUMINURIA 1 0.0019
128 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
129 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
130 AUTOIMMUNE THYROIDITIS 7 0.0018
131 OESOPHAGEAL FOOD IMPACTION 1 0.0018
132 BLOOD GROWTH HORMONE INCREASED 1 0.0018
133 INJECTION SITE HAEMORRHAGE 142 0.0018
134 JUGULAR VEIN DISTENSION 1 0.0018
135 METAL POISONING 1 0.0017
136 INDURATION 3 0.0017
137 ADRENAL ADENOMA 1 0.0017
138 MALE SEXUAL DYSFUNCTION 1 0.0017
139 PRODUCT TAMPERING 3 0.0017
140 INJURY ASSOCIATED WITH DEVICE 34 0.0017
141 BEHAVIOUR DISORDER 9 0.0017
142 INJECTION SITE MASS 61 0.0016
143 FAT NECROSIS 1 0.0016
144 PROSTATE CANCER RECURRENT 1 0.0016
145 ELBOW OPERATION 1 0.0016
146 ARTHRITIS REACTIVE 1 0.0016
147 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
148 EXTREMITY CONTRACTURE 1 0.0016
149 PREMATURE EJACULATION 1 0.0016
150 CALCIUM DEFICIENCY 2 0.0015
151 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
152 FASCIITIS 1 0.0015
153 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
154 PUSTULAR PSORIASIS 5 0.0015
155 INJECTION SITE INJURY 8 0.0014
156 BORDERLINE PERSONALITY DISORDER 1 0.0014
157 PSEUDOMONAS INFECTION 12 0.0014
158 FAT TISSUE INCREASED 2 0.0014
159 BRAIN CONTUSION 1 0.0014
160 OVARIAN MASS 1 0.0014
161 HAEMOGLOBIN INCREASED 6 0.0013
162 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
163 METAPNEUMOVIRUS INFECTION 1 0.0013
164 DIARRHOEA INFECTIOUS 1 0.0013
165 FAECAL CALPROTECTIN INCREASED 4 0.0013
166 INTERMITTENT CLAUDICATION 2 0.0013
167 GOUTY ARTHRITIS 1 0.0013
168 IIIRD NERVE PARALYSIS 1 0.0012
169 PITUITARY TUMOUR BENIGN 2 0.0012
170 PRODUCT DOSE OMISSION ISSUE 354 0.0012
171 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 22 0.0012
172 LUNG OPERATION 1 0.0012
173 DENTAL DISCOMFORT 1 0.0012
174 CEREBELLAR INFARCTION 2 0.0012
175 PRIAPISM 4 0.0012
176 AXONAL NEUROPATHY 1 0.0011
177 LACK OF INJECTION SITE ROTATION 2 0.0011
178 ROTATOR CUFF REPAIR 2 0.0011
179 SENSITIVITY TO WEATHER CHANGE 6 0.0011
180 ANOGENITAL WARTS 1 0.0011
181 EOSINOPHILIC OESOPHAGITIS 3 0.0011
182 HAEMOCHROMATOSIS 1 0.0011
183 ORAL ADMINISTRATION COMPLICATION 1 0.0011
184 IMPULSIVE BEHAVIOUR 4 0.0011
185 HEPATIC CONGESTION 1 0.0011
186 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
187 CARDIAC FAILURE ACUTE 7 0.0010
188 PROSTATE INFECTION 1 0.0010
189 INCORRECT DOSE ADMINISTERED BY DEVICE 27 0.0010
190 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
191 INJECTION SITE INFLAMMATION 5 0.0010
192 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
193 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
194 FRUSTRATION TOLERANCE DECREASED 8 0.0010
195 ORAL CANDIDIASIS 13 0.0010
196 HYPOCHROMIC ANAEMIA 1 0.0010
197 CAROTID ARTERIOSCLEROSIS 1 0.0010
198 BREAST DISCOMFORT 1 0.0010
199 INSULIN RESISTANCE 2 0.0010
200 CARPAL TUNNEL DECOMPRESSION 1 0.0009
201 BONE DEMINERALISATION 1 0.0009
202 CARDIAC FAILURE CHRONIC 4 0.0009
203 VENTRICULAR HYPOKINESIA 3 0.0009
204 JOINT CONTRACTURE 1 0.0009
205 INJECTION SITE INDENTATION 2 0.0009
206 KIDNEY ENLARGEMENT 1 0.0009
207 INJECTION SITE NODULE 10 0.0009
208 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
209 MYOCARDIAL INJURY 1 0.0009
210 CORTISOL DECREASED 1 0.0009
211 PROCALCITONIN INCREASED 1 0.0009
212 INTRUSIVE THOUGHTS 1 0.0008
213 DEVICE DISPENSING ERROR 1 0.0008
214 LACUNAR INFARCTION 2 0.0008
215 POST-ACUTE COVID-19 SYNDROME 1 0.0008
216 TENDON INJURY 3 0.0008
217 PRODUCT DOSE OMISSION 52 0.0008
218 PRODUCT ADMINISTRATION ERROR 16 0.0008
219 UNRESPONSIVE TO STIMULI 20 0.0008
220 INJECTION SITE INDURATION 10 0.0008
221 LIBIDO DISORDER 1 0.0008
222 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
223 FEELINGS OF WORTHLESSNESS 1 0.0008
224 EXTRADURAL HAEMATOMA 1 0.0008
225 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
226 LIP EXFOLIATION 1 0.0008
227 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
228 EFFUSION 1 0.0007
229 APPLICATION SITE INFLAMMATION 1 0.0007
230 CONGESTIVE CARDIOMYOPATHY 3 0.0007
231 CHRONIC FATIGUE SYNDROME 1 0.0007
232 INTESTINAL FISTULA 1 0.0007
233 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
234 INJECTION SITE BRUISING 56 0.0007
235 PELVIC VENOUS THROMBOSIS 1 0.0007
236 DYSPNOEA AT REST 2 0.0007
237 GROWTH RETARDATION 2 0.0007
238 APRAXIA 1 0.0007
239 INFUSION SITE REACTION 2 0.0007
240 INFERTILITY 1 0.0007
241 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
242 INJECTION SITE HYPERSENSITIVITY 2 0.0006
243 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
244 SUBSTANCE ABUSE 5 0.0006
245 METABOLIC SYNDROME 1 0.0006
246 INTESTINAL POLYP 1 0.0006
247 DEAFNESS NEUROSENSORY 2 0.0006
248 HAEMATOCRIT DECREASED 12 0.0006
249 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
250 PROSTATE CANCER METASTATIC 2 0.0006
251 DYSLIPIDAEMIA 3 0.0006
252 CERVICAL SPINAL STENOSIS 1 0.0006
253 CHOREA 1 0.0006
254 BLOOD CHLORIDE INCREASED 1 0.0006
255 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
256 DRUG SCREEN NEGATIVE 1 0.0006
257 MITRAL VALVE DISEASE 1 0.0006
258 OBSESSIVE THOUGHTS 1 0.0006
259 INJECTION SITE IRRITATION 7 0.0005
260 ESSENTIAL HYPERTENSION 1 0.0005
261 SEBORRHOEA 2 0.0005
262 BLOOD CHOLESTEROL DECREASED 1 0.0005
263 HYPERTENSIVE HEART DISEASE 1 0.0005
264 CYSTOID MACULAR OEDEMA 1 0.0005
265 SNORING 2 0.0005
266 MECHANICAL VENTILATION 1 0.0005
267 HYPERCOAGULATION 1 0.0005
268 INJECTION SITE PAIN 160 0.0005
269 ADRENAL DISORDER 1 0.0005
270 ACCIDENTAL EXPOSURE TO PRODUCT 53 0.0005
271 MUSCLE RUPTURE 2 0.0005
272 CONCOMITANT DISEASE PROGRESSION 1 0.0005
273 NASAL SEPTUM DEVIATION 1 0.0005
274 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
275 PROSTATIC SPECIFIC ANTIGEN INCREASED 7 0.0005
276 HYPERPHAGIA 2 0.0005
277 ATRIAL FLUTTER 4 0.0005
278 CORONARY ARTERY THROMBOSIS 1 0.0005
279 NIPPLE PAIN 1 0.0005
280 CARDIOGENIC SHOCK 7 0.0005
281 SELF-MEDICATION 2 0.0005
282 CHEST INJURY 1 0.0005
283 ANAL PRURITUS 1 0.0005
284 INJECTION SITE DISCOLOURATION 6 0.0005
285 DEVICE CONNECTION ISSUE 1 0.0005
286 SLEEP APNOEA SYNDROME 9 0.0005
287 LIPODYSTROPHY ACQUIRED 1 0.0005
288 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
289 CD4 LYMPHOCYTES DECREASED 1 0.0005
290 DEREALISATION 1 0.0005
291 LIMB MASS 1 0.0005
292 ENDOMETRIAL CANCER 1 0.0005
293 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
294 CHOLESTATIC LIVER INJURY 1 0.0004
295 BACTERIAL TEST POSITIVE 1 0.0004
296 APPLICATION SITE URTICARIA 1 0.0004
297 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
298 EAR DISORDER 2 0.0004
299 MYOCARDITIS 5 0.0004
300 NECK SURGERY 1 0.0004
301 ESCHERICHIA BACTERAEMIA 1 0.0004
302 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
303 VISUAL FIELD DEFECT 3 0.0004
304 DEVICE DISLOCATION 18 0.0004
305 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
306 RASH PUSTULAR 3 0.0004
307 DERMAL CYST 1 0.0004
308 CARDIOMEGALY 5 0.0004
309 DEVICE INFUSION ISSUE 1 0.0004
310 EYELID IRRITATION 1 0.0004
311 DRUG ABUSE 33 0.0004
312 TENDON PAIN 3 0.0004
313 HAEMORRHAGE URINARY TRACT 1 0.0004
314 LACTOSE INTOLERANCE 1 0.0004
315 PHYSICAL DECONDITIONING 1 0.0004
316 VARICOSE VEIN 2 0.0004
317 DEVICE MALFUNCTION 27 0.0004
318 HEPATITIS TOXIC 1 0.0004
319 TENDERNESS 4 0.0004
320 SERUM FERRITIN INCREASED 2 0.0004
321 ABDOMINAL MASS 1 0.0004
322 PHARYNGITIS STREPTOCOCCAL 4 0.0004
323 DEEP VEIN THROMBOSIS 24 0.0004
324 MIGRAINE WITH AURA 1 0.0004
325 HYPERAESTHESIA 3 0.0004
326 DRUG SCREEN FALSE POSITIVE 1 0.0004
327 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
328 CEREBRAL THROMBOSIS 1 0.0004
329 EJACULATION DISORDER 1 0.0004
330 INTENTIONAL DOSE OMISSION 10 0.0004
331 HYPERTONIC BLADDER 1 0.0003
332 EYELID MARGIN CRUSTING 1 0.0003
333 SKIN WARM 2 0.0003
334 DEVICE POWER SOURCE ISSUE 1 0.0003
335 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
336 LUMBAR SPINAL STENOSIS 1 0.0003
337 NEGATIVE THOUGHTS 1 0.0003
338 ACUTE MYOCARDIAL INFARCTION 10 0.0003
339 CARDIOMYOPATHY 5 0.0003
340 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
341 LOSS OF LIBIDO 3 0.0003
342 CEREBROVASCULAR DISORDER 1 0.0003
343 HIV INFECTION 1 0.0003
344 INJECTION SITE ERYTHEMA 41 0.0003
345 CRANIOCEREBRAL INJURY 1 0.0003
346 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
347 DRUG DIVERSION 2 0.0003
348 PERSONALITY CHANGE 3 0.0003
349 PHARYNGITIS 4 0.0003
350 EYELIDS PRURITUS 1 0.0003
351 BLOOD CREATININE DECREASED 1 0.0003
352 ORTHOPNOEA 1 0.0003
353 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
354 INJECTION SITE SWELLING 24 0.0003
355 ACUTE RESPIRATORY FAILURE 6 0.0003
356 BRADYPHRENIA 2 0.0003
357 INJECTION SITE INFECTION 1 0.0003
358 PRODUCT FORMULATION ISSUE 2 0.0003
359 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
360 ANXIETY DISORDER 1 0.0003
361 BRAIN INJURY 3 0.0003
362 INJECTION SITE PRURITUS 20 0.0003
363 NEOPLASM RECURRENCE 1 0.0003
364 SLUGGISHNESS 3 0.0003
365 INJECTION SITE RASH 9 0.0003
366 NEPHROTIC SYNDROME 2 0.0003
367 HEPATIC FIBROSIS 1 0.0003
368 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
369 MICTURITION DISORDER 1 0.0003
370 SCRATCH 3 0.0003
371 BRONCHIOLITIS 1 0.0003
372 FIBRIN D DIMER INCREASED 1 0.0003
373 PRODUCT CONTAMINATION 1 0.0003
374 FEAR OF INJECTION 2 0.0003
375 LETHARGY 16 0.0003
376 CARDIOVASCULAR DISORDER 7 0.0003
377 CAROTID ARTERY OCCLUSION 1 0.0003
378 ERECTILE DYSFUNCTION 7 0.0003
379 SENSITIVE SKIN 2 0.0003
380 LEUKOENCEPHALOPATHY 1 0.0003
381 BLOOD CALCIUM DECREASED 3 0.0003
382 ANHEDONIA 7 0.0003
383 PARANASAL SINUS DISCOMFORT 1 0.0003
384 CLAVICLE FRACTURE 1 0.0003
385 CONCUSSION 2 0.0003
386 MOOD ALTERED 7 0.0003
387 PULMONARY HAEMORRHAGE 2 0.0003
388 BLOOD ALBUMIN DECREASED 2 0.0003
389 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
390 HYPERLIPIDAEMIA 3 0.0003
391 BLEPHARITIS 1 0.0002
392 ATRIAL FIBRILLATION 24 0.0002
393 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
394 PERIPHERAL ISCHAEMIA 1 0.0002
395 INJECTION SITE URTICARIA 6 0.0002
396 ANAPHYLACTOID REACTION 1 0.0002
397 HEMIPLEGIA 2 0.0002
398 ERECTION INCREASED 1 0.0002
399 MUSCLE ATROPHY 3 0.0002
400 HYPERPYREXIA 1 0.0002
401 MUSCLE FATIGUE 1 0.0002
402 COGNITIVE DISORDER 11 0.0002
403 AORTIC VALVE INCOMPETENCE 1 0.0002
404 ABSCESS LIMB 1 0.0002
405 LUNG NEOPLASM 1 0.0002
406 VITAMIN D DECREASED 2 0.0002
407 INFUSION SITE PAIN 3 0.0002
408 MULTI-ORGAN FAILURE 4 0.0002
409 HEPATIC LESION 1 0.0002
410 CORONARY ARTERY DISEASE 7 0.0002
411 CHAPPED LIPS 1 0.0002
412 DEVICE USE ERROR 8 0.0002
413 MONOPLEGIA 1 0.0002
414 MELANOCYTIC NAEVUS 1 0.0002
415 SPINAL OSTEOARTHRITIS 2 0.0002
416 PULMONARY CONGESTION 3 0.0002
417 INTENTIONAL DEVICE MISUSE 1 0.0002
418 LUNG INFILTRATION 2 0.0002
419 PHYSICAL DISABILITY 1 0.0002
420 MALIGNANT MELANOMA 3 0.0002
421 EXOSTOSIS 2 0.0002
422 BRAIN NEOPLASM 2 0.0002
423 ISCHAEMIA 1 0.0002
424 RETINAL DETACHMENT 2 0.0002
425 INCREASED TENDENCY TO BRUISE 2 0.0002
426 NEPHROGENIC ANAEMIA 1 0.0002
427 BLOOD TEST ABNORMAL 3 0.0002
428 SQUAMOUS CELL CARCINOMA 2 0.0002
429 SPUTUM DISCOLOURED 2 0.0002
430 PULMONARY EMBOLISM 20 0.0002
431 PRODUCT USE ISSUE 39 0.0002
432 DIZZINESS POSTURAL 2 0.0002
433 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
434 EAR PAIN 4 0.0002
435 APATHY 3 0.0002
436 HORMONE LEVEL ABNORMAL 1 0.0002
437 INCORRECT DOSAGE ADMINISTERED 1 0.0002
438 DIABETIC NEUROPATHY 1 0.0002
439 ABDOMINAL TENDERNESS 1 0.0002
440 ANEURYSM 1 0.0002
441 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
442 OSTEOPENIA 3 0.0002
443 CORONARY ARTERIAL STENT INSERTION 1 0.0002
444 FEBRILE NEUTROPENIA 13 0.0002
445 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
446 INTENTIONAL PRODUCT MISUSE 17 0.0002
447 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
448 RHABDOMYOLYSIS 8 0.0002
449 INJECTION SITE DISCOMFORT 2 0.0002
450 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
451 NYSTAGMUS 1 0.0002
452 OBESITY 3 0.0002
453 BODY HEIGHT DECREASED 2 0.0002
454 NIGHT SWEATS 6 0.0002
455 DECREASED ACTIVITY 2 0.0002
456 FREQUENT BOWEL MOVEMENTS 5 0.0002
457 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
458 SKIN LACERATION 2 0.0002
459 ASTHENOPIA 1 0.0002
460 PROSTATIC DISORDER 1 0.0002
461 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
462 INTERMENSTRUAL BLEEDING 1 0.0002
463 HEMIPARESIS 3 0.0002
464 AGITATION 13 0.0002
465 PREMATURE LABOUR 1 0.0002
466 BLOOD PRESSURE INCREASED 27 0.0002
467 PERONEAL NERVE PALSY 1 0.0002
468 NEUTROPHILIA 1 0.0002
469 CORONARY ARTERY BYPASS 1 0.0002
470 EXERCISE TOLERANCE DECREASED 1 0.0002
471 HERPES VIRUS INFECTION 1 0.0002
472 BLOOD URIC ACID INCREASED 1 0.0002
473 NEOPLASM PROGRESSION 6 0.0002
474 POST PROCEDURAL HAEMORRHAGE 2 0.0002
475 CEREBROVASCULAR ACCIDENT 29 0.0002
476 HEART RATE DECREASED 6 0.0002
477 SPLENOMEGALY 2 0.0002
478 DIABETES MELLITUS 13 0.0002
479 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
480 DECREASED INTEREST 1 0.0002
481 ENERGY INCREASED 1 0.0002
482 LEUKOCYTOSIS 3 0.0002
483 CEREBRAL INFARCTION 4 0.0002
484 TENDON RUPTURE 2 0.0002
485 GENERALISED OEDEMA 2 0.0002
486 OLIGURIA 1 0.0002
487 PRE-EXISTING CONDITION IMPROVED 1 0.0002
488 OXYGEN SATURATION DECREASED 9 0.0002
489 INJECTION SITE REACTION 11 0.0002
490 PHOTOPHOBIA 3 0.0002
491 PROTEINURIA 3 0.0002
492 FLUID RETENTION 8 0.0002
493 MIGRAINE 15 0.0002
494 FOREIGN BODY SENSATION IN EYES 1 0.0002
495 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
496 HAEMOGLOBIN ABNORMAL 1 0.0002
497 INFLAMMATION 8 0.0002
498 HEPATITIS ACUTE 1 0.0002
499 PLATELET COUNT INCREASED 2 0.0002
500 PRODUCT PREPARATION ISSUE 1 0.0002
501 DISABILITY 3 0.0002
502 MENINGITIS 1 0.0001
503 SPINAL FRACTURE 3 0.0001
504 POST-TRAUMATIC STRESS DISORDER 1 0.0001
505 QUALITY OF LIFE DECREASED 2 0.0001
506 MYOCARDIAL INFARCTION 26 0.0001
507 METASTASES TO LYMPH NODES 1 0.0001
508 DRUG TOXICITY 2 0.0001
509 AKATHISIA 2 0.0001
510 HYPERTENSION 31 0.0001
511 INFARCTION 1 0.0001
512 EYE MOVEMENT DISORDER 1 0.0001
513 PRODUCT PREPARATION ERROR 3 0.0001
514 ECCHYMOSIS 1 0.0001
515 RIB FRACTURE 3 0.0001
516 JOINT EFFUSION 1 0.0001
517 LYMPHOEDEMA 1 0.0001
518 LARGE INTESTINE POLYP 1 0.0001
519 HYPERTRANSAMINASAEMIA 1 0.0001
520 FORMICATION 1 0.0001
521 FEELING COLD 4 0.0001
522 AGGRESSION 7 0.0001
523 GRAFT VERSUS HOST DISEASE 1 0.0001
524 ACCIDENTAL UNDERDOSE 2 0.0001
525 AMNESIA 9 0.0001
526 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
527 INJECTION SITE HAEMATOMA 2 0.0001
528 HYPOKINESIA 2 0.0001
529 FLUID OVERLOAD 2 0.0001
530 PANIC ATTACK 5 0.0001
531 CARDIAC FAILURE CONGESTIVE 11 0.0001
532 INTENTIONAL UNDERDOSE 1 0.0001
533 MOUTH HAEMORRHAGE 1 0.0001
534 HAEMOGLOBIN DECREASED 14 0.0001
535 INCORRECT DOSE ADMINISTERED 31 0.0001
536 BLINDNESS TRANSIENT 1 0.0001
537 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
538 CEREBRAL DISORDER 1 0.0001
539 TRANSAMINASES INCREASED 3 0.0001
540 FEELING DRUNK 1 0.0001
541 COLITIS ULCERATIVE 6 0.0001
542 CHROMATURIA 3 0.0001
543 BREAST TENDERNESS 1 0.0001
544 HOT FLUSH 10 0.0001
545 DEPRESSED MOOD 7 0.0001
546 ECONOMIC PROBLEM 2 0.0001
547 AORTIC ANEURYSM 1 0.0001
548 HYPERTHERMIA 1 0.0001
549 INSURANCE ISSUE 2 0.0001
550 LIPASE INCREASED 1 0.0001
551 ATRIOVENTRICULAR BLOCK 1 0.0001
552 GYNAECOMASTIA 4 0.0001
553 MUSCULOSKELETAL CHEST PAIN 2 0.0001
554 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
555 OEDEMA 7 0.0001
556 APNOEA 1 0.0001
557 BASAL CELL CARCINOMA 2 0.0001
558 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
559 BRAIN FOG 2 0.0001
560 DRUG-INDUCED LIVER INJURY 4 0.0001
561 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
562 PRODUCT USE COMPLAINT 2 0.0001
563 PROSTATE CANCER 10 0.0001
564 THROMBOSIS 10 0.0001
565 MUSCLE DISORDER 1 0.0001
566 EXTRA DOSE ADMINISTERED 5 0.0001
567 POST PROCEDURAL INFECTION 1 0.0001
568 POLYURIA 1 0.0001
569 OSTEONECROSIS 4 0.0001
570 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
571 ACUTE CORONARY SYNDROME 1 0.0001
572 AGEUSIA 3 0.0001
573 EOSINOPHIL COUNT INCREASED 1 0.0001
574 HAEMODIALYSIS 1 0.0001
575 CHRONIC KIDNEY DISEASE 9 0.0001
576 SCAR 2 0.0001
577 CARDIAC OPERATION 1 0.0001
578 MUSCLE STRAIN 1 0.0001
579 CARDIAC MURMUR 1 0.0001
580 DEVICE USE ISSUE 2 0.0001
581 PRODUCT STORAGE ERROR 10 0.0001
582 OFF LABEL USE 100 0.0001
583 DRUG WITHDRAWAL SYNDROME 10 0.0001
584 HYPOXIA 4 0.0001
585 LYMPHADENOPATHY 4 0.0001
586 HEAD DISCOMFORT 2 0.0001
587 FACIAL PAIN 1 0.0001
588 JAUNDICE 3 0.0001
589 GOUT 2 0.0001
590 DEVELOPMENTAL DELAY 1 0.0001
591 OROPHARYNGEAL DISCOMFORT 1 0.0001
592 GASTROINTESTINAL CARCINOMA 1 0.0001
593 LIP DRY 1 0.0001
594 RESTLESS LEGS SYNDROME 2 0.0001
595 END STAGE RENAL DISEASE 2 0.0001
596 PNEUMONIA BACTERIAL 1 0.0001
597 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
598 HYPERHIDROSIS 14 0.0001
599 GRAND MAL CONVULSION 1 0.0001
600 HEPATIC FUNCTION ABNORMAL 4 0.0001
601 RENAL IMPAIRMENT 9 0.0001
602 NEPHROPATHY 1 0.0001
603 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
604 DYSPNOEA EXERTIONAL 4 0.0001
605 LEUKAEMIA 1 0.0001
606 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
607 PAIN IN JAW 3 0.0001
608 ACNE 8 0.0001
609 FOOT FRACTURE 2 0.0001
610 BLOOD PRESSURE DECREASED 7 0.0001
611 ANGINA PECTORIS 3 0.0001
612 INCREASED APPETITE 2 0.0001
613 PULMONARY FIBROSIS 2 0.0001
614 PRODUCT SUBSTITUTION ISSUE 6 0.0001
615 ATELECTASIS 1 0.0001
616 HERNIA 2 0.0001
617 PRESCRIBED OVERDOSE 2 0.0001
618 AUTOIMMUNE DISORDER 1 0.0001
619 PARKINSONISM 1 0.0001
620 CHOKING 2 0.0001
621 ORAL HERPES 2 0.0001
622 PHARYNGEAL SWELLING 1 0.0001
623 HEPATOMEGALY 1 0.0001
624 LIGAMENT SPRAIN 1 0.0001
625 BLADDER DISORDER 1 0.0001
626 CELLULITIS 5 0.0001
627 EUPHORIC MOOD 1 0.0001
628 INITIAL INSOMNIA 1 0.0001
629 EAR DISCOMFORT 1 0.0001
630 INJECTION SITE WARMTH 2 0.0001
631 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
632 RENAL FAILURE ACUTE 4 0.0001
633 HYPOTHYROIDISM 3 0.0001
634 EATING DISORDER 2 0.0001
635 POOR QUALITY SLEEP 2 0.0001
636 RASH PRURITIC 5 0.0001
637 BIPOLAR DISORDER 1 0.0001
638 MENTAL DISORDER 4 0.0001
639 PRODUCT PRESCRIBING ISSUE 2 0.0001
640 EYE DISORDER 3 0.0001
641 DENTAL CARIES 1 0.0001
642 BACK PAIN 21 0.0001
643 INFLUENZA 10 0.0001
644 EYE PRURITUS 3 0.0001
645 PANCREATITIS ACUTE 2 0.0001
646 IMPAIRED DRIVING ABILITY 1 0.0001
647 MYOCARDIAL ISCHAEMIA 1 0.0001
648 SKIN IRRITATION 4 0.0001
649 SKIN DISCOLOURATION 4 0.0001
650 OROPHARYNGEAL PAIN 8 0.0001
651 PALPITATIONS 10 0.0001
652 INFLUENZA LIKE ILLNESS 7 0.0001
653 SLEEP DISORDER 6 0.0001
654 WEIGHT INCREASED 19 0.0001
655 DRUG INEFFECTIVE 111 0.0001
656 PRODUCT PRESCRIBING ERROR 2 0.0001
657 PRODUCTIVE COUGH 4 0.0001
658 ADRENAL INSUFFICIENCY 1 0.0001
659 NOCTURIA 1 0.0001
660 NO THERAPEUTIC RESPONSE 1 0.0001
661 CYTOPENIA 1 0.0001
662 FEELING HOT 5 0.0001
663 ENCEPHALOPATHY 2 0.0001
664 MUSCLE SPASTICITY 1 0.0001
665 HYPERCALCAEMIA 1 0.0001
666 ABNORMAL WEIGHT GAIN 1 0.0001
667 CYST 1 0.0001
668 ILEUS 1 0.0001
669 APPLICATION SITE IRRITATION 1 0.0001
670 DRY EYE 4 0.0001
671 ASTHENIA 30 0.0001
672 POISONING 1 0.0001
673 BRAIN OEDEMA 1 0.0001
674 FLUSHING 8 0.0001
675 INTRAOCULAR PRESSURE INCREASED 1 0.0001
676 HEPATITIS 2 0.0001
677 GASTROINTESTINAL DISORDER 7 0.0001
678 RHINORRHOEA 5 0.0001
679 HAEMATOMA 2 0.0001
680 NODULE 1 0.0001
681 BLOOD CREATININE INCREASED 5 0.0001
682 SUICIDAL IDEATION 7 0.0001
683 BRADYCARDIA 4 0.0001
684 BLOOD BILIRUBIN INCREASED 2 0.0001
685 PSORIATIC ARTHROPATHY 3 0.0001
686 DEVICE BREAKAGE 3 0.0001
687 ANXIETY 21 0.0001
688 NEUTROPHIL COUNT DECREASED 3 0.0001
689 IMPAIRED GASTRIC EMPTYING 1 0.0001
690 FATIGUE 57 0.0001
691 ACUTE HEPATIC FAILURE 1 0.0001
692 TREATMENT NONCOMPLIANCE 4 0.0001
693 CORONARY ARTERY OCCLUSION 1 0.0001
694 PERIPHERAL COLDNESS 1 0.0001
695 PROCEDURAL PAIN 2 0.0001
696 HUNGER 1 0.0001
697 HAEMOPTYSIS 2 0.0001
698 APHONIA 1 0.0001
699 MASS 1 0.0001
700 WITHDRAWAL SYNDROME 3 0.0001
701 DEVICE OCCLUSION 1 0.0001
702 HYPONATRAEMIA 4 0.0001
703 OSTEOARTHRITIS 3 0.0001
704 HEART RATE INCREASED 7 0.0001
705 DEPRESSION 16 0.0001
706 RED BLOOD CELL COUNT DECREASED 2 0.0001
707 RECTAL HAEMORRHAGE 3 0.0001
708 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
709 ANOSMIA 1 0.0001
710 LIVER FUNCTION TEST ABNORMAL 2 0.0001
711 NEEDLE ISSUE 2 0.0001
712 UNDERDOSE 5 0.0001
713 CHEST DISCOMFORT 7 0.0001
714 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
715 SURGERY 4 0.0001
716 ERYTHEMA 14 0.0001
717 WEIGHT DECREASED 19 0.0001
718 LABORATORY TEST ABNORMAL 2 0.0001
719 BRONCHITIS 5 0.0001
720 RENAL INJURY 2 0.0001
721 PULMONARY OEDEMA 3 0.0001
722 DEVICE ISSUE 6 0.0001
723 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
724 FEELING ABNORMAL 16 0.0001
725 BONE LOSS 1 0.0001
726 IRRITABILITY 4 0.0001
727 HYPOAESTHESIA ORAL 1 0.0001
728 APHASIA 2 0.0001
729 LACRIMATION INCREASED 2 0.0001
730 UNEVALUABLE EVENT 5 0.0001
731 DEVICE FAILURE 1 0.0001
732 DISCOMFORT 4 0.0001
733 TINNITUS 3 0.0001
734 HIP ARTHROPLASTY 1 0.0001
735 ADVERSE EVENT 6 0.0001
736 DEVICE RELATED INFECTION 1 0.0001
737 EMOTIONAL DISORDER 2 0.0001
738 HYPERSENSITIVITY 12 0.0001
739 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
740 VISUAL IMPAIRMENT 8 0.0001
741 DELUSION 1 0.0001
742 BLOOD CHOLESTEROL INCREASED 3 0.0001
743 EJECTION FRACTION DECREASED 1 0.0001
744 MENINGIOMA 1 0.0001
745 BONE DENSITY DECREASED 2 0.0001
746 INSOMNIA 17 0.0001
747 PYREXIA 22 0.0001
748 PARAESTHESIA 10 0.0001
749 OCULAR HYPERAEMIA 3 0.0001
750 HEAD INJURY 2 0.0001
751 HALLUCINATION, AUDITORY 1 0.0001
752 MOOD SWINGS 2 0.0001
753 ABSCESS 1 0.0001
754 CARDIAC FAILURE 5 0.0001
755 DRY MOUTH 5 0.0001
756 BLOOD POTASSIUM INCREASED 1 0.0001
757 BACK DISORDER 1 0.0001
758 METASTASES TO BONE 1 0.0001
759 MULTIPLE FRACTURES 1 0.0001
760 DRUG LEVEL INCREASED 1 0.0001
761 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
762 VISUAL ACUITY REDUCED 2 0.0001
763 ABDOMINAL PAIN 14 0.0001
764 EXPIRED PRODUCT ADMINISTERED 2 0.0001
765 LEUKOPENIA 3 0.0001
766 PRURITUS 23 0.0001
767 GAIT INABILITY 2 0.0001
768 BLOOD UREA INCREASED 1 0.0001
769 TYPE 2 DIABETES MELLITUS 2 0.0001
770 FACE OEDEMA 1 0.0001
771 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
772 THERAPY CESSATION 3 0.0001
773 MUSCULOSKELETAL DISCOMFORT 1 0.0001
774 NIGHTMARE 2 0.0001
775 OEDEMA PERIPHERAL 7 0.0001
776 COUGH 16 0.0001
777 AMENORRHOEA 1 0.0001
778 DERMATITIS ATOPIC 3 0.0001
779 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
780 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
781 ISCHAEMIC STROKE 1 0.0001
782 GALLBLADDER DISORDER 1 0.0001
783 THERAPY INTERRUPTED 4 0.0001
784 CEREBRAL HAEMORRHAGE 2 0.0001
785 PELVIC PAIN 1 0.0001
786 CRYING 2 0.0001
787 HYPERGLYCAEMIA 2 0.0001
788 LOSS OF CONSCIOUSNESS 7 0.0001
789 BLOOD GLUCOSE ABNORMAL 1 0.0001
790 DIZZINESS 27 0.0001
791 CONJUNCTIVITIS 1 0.0001
792 URTICARIA 9 0.0001
793 BLISTER 3 0.0001
794 HEPATIC CIRRHOSIS 1 0.0001
795 BLOOD GLUCOSE INCREASED 10 0.0001
796 INTESTINAL OBSTRUCTION 2 0.0001
797 HYPOCALCAEMIA 1 0.0001
798 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
799 DRUG PRESCRIBING ERROR 1 0.0001
800 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
801 DYSTONIA 1 0.0001
802 DYSPHONIA 3 0.0001
803 MEMORY IMPAIRMENT 7 0.0001
804 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
805 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
806 FULL BLOOD COUNT DECREASED 1 0.0000
807 PRODUCT PHYSICAL ISSUE 1 0.0000
808 EMOTIONAL DISTRESS 6 0.0000
809 INTENTIONAL SELF-INJURY 1 0.0000
810 VERTIGO 3 0.0000
811 BONE MARROW FAILURE 1 0.0000
812 MUSCLE SPASMS 9 0.0000
813 BODY TEMPERATURE INCREASED 1 0.0000
814 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
815 SINUSITIS 5 0.0000
816 OSTEOPOROSIS 2 0.0000
817 ARTHRALGIA 20 0.0000
818 POLLAKIURIA 2 0.0000
819 INTENTIONAL DRUG MISUSE 1 0.0000
820 CARDIO-RESPIRATORY ARREST 2 0.0000
821 HAEMORRHAGE 5 0.0000
822 DERMATITIS 1 0.0000
823 MOUTH ULCERATION 1 0.0000
824 HALLUCINATION, VISUAL 1 0.0000
825 DECREASED APPETITE 11 0.0000
826 ANAEMIA 9 0.0000
827 MYALGIA 8 0.0000
828 HYPOAESTHESIA 7 0.0000
829 LIVER FUNCTION TEST INCREASED 1 0.0000
830 HYPOACUSIS 2 0.0000
831 DEVICE LEAKAGE 2 0.0000
832 PRODUCT DISPENSING ERROR 1 0.0000
833 RASH 20 0.0000
834 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
835 MUSCULOSKELETAL STIFFNESS 4 0.0000
836 DEVICE DIFFICULT TO USE 3 0.0000
837 RENAL FAILURE 6 0.0000
838 TACHYCARDIA 4 0.0000
839 DIARRHOEA 29 0.0000
840 GLOSSODYNIA 1 0.0000
841 HEART RATE IRREGULAR 1 0.0000
842 PRODUCT AVAILABILITY ISSUE 1 0.0000
843 HYPOKALAEMIA 2 0.0000
844 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
845 RENAL DISORDER 2 0.0000
846 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
847 BURNING SENSATION 3 0.0000
848 CARDIAC DISORDER 4 0.0000
849 PAIN 26 0.0000
850 DISEASE RECURRENCE 2 0.0000
851 RASH ERYTHEMATOUS 2 0.0000
852 BLOOD GLUCOSE DECREASED 2 0.0000
853 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
854 DIABETIC KETOACIDOSIS 1 0.0000
855 CONTUSION 4 0.0000
856 MENTAL IMPAIRMENT 1 0.0000
857 NEURALGIA 1 0.0000
858 LUNG DISORDER 2 0.0000
859 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
860 PNEUMONIA 13 0.0000
861 EPISTAXIS 3 0.0000
862 SYNCOPE 4 0.0000
863 COVID-19 7 0.0000
864 HEADACHE 25 0.0000
865 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
866 ABDOMINAL PAIN LOWER 1 0.0000
867 ACUTE KIDNEY INJURY 6 0.0000
868 DRUG RESISTANCE 1 0.0000
869 EXPOSURE VIA SKIN CONTACT 1 0.0000
870 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
871 NERVOUSNESS 2 0.0000
872 DEAFNESS 1 0.0000
873 MUCOSAL INFLAMMATION 1 0.0000
874 APPLICATION SITE ERYTHEMA 1 0.0000
875 GASTRITIS 1 0.0000
876 PANCREATITIS 2 0.0000
877 CHEST PAIN 7 0.0000
878 EAR INFECTION 1 0.0000
879 FEAR 1 0.0000
880 DYSPNOEA 21 0.0000
881 DISTURBANCE IN ATTENTION 2 0.0000
882 LIMB INJURY 1 0.0000
883 PALLOR 1 0.0000
884 PNEUMONITIS 1 0.0000
885 MALAISE 16 0.0000
886 CARDIAC ARREST 3 0.0000
887 DIVERTICULITIS 1 0.0000
888 MENTAL STATUS CHANGES 1 0.0000
889 ARTHROPATHY 2 0.0000
890 MEDICATION ERROR 2 0.0000
891 ALOPECIA 7 0.0000
892 SKIN EXFOLIATION 3 0.0000
893 EYE PAIN 2 0.0000
894 ASTHMA 4 0.0000
895 NAUSEA 28 0.0000
896 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
897 FLATULENCE 2 0.0000
898 MUSCULAR WEAKNESS 4 0.0000
899 HYPERSOMNIA 1 0.0000
900 HERPES ZOSTER 2 0.0000
901 SEIZURE 4 0.0000
902 NASAL CONGESTION 2 0.0000
903 ABDOMINAL PAIN UPPER 7 0.0000
904 BLOOD POTASSIUM DECREASED 1 0.0000
905 HEPATIC FAILURE 1 0.0000
906 PLEURAL EFFUSION 2 0.0000
907 DRUG ADMINISTRATION ERROR 1 0.0000
908 PERIPHERAL SWELLING 5 0.0000
909 FEMUR FRACTURE 1 0.0000
910 SWELLING 3 0.0000
911 NERVOUS SYSTEM DISORDER 1 0.0000
912 DYSPHAGIA 3 0.0000
913 NEUROPATHY PERIPHERAL 3 0.0000
914 DRUG INTERACTION 5 0.0000
915 METABOLIC ACIDOSIS 1 0.0000
916 MOVEMENT DISORDER 1 0.0000
917 DRUG DEPENDENCE 5 0.0000
918 HIP FRACTURE 1 0.0000
919 CONFUSIONAL STATE 5 0.0000
920 SWELLING FACE 2 0.0000
921 DYSPEPSIA 3 0.0000
922 LIP SWELLING 1 0.0000
923 DEHYDRATION 4 0.0000
924 NEOPLASM MALIGNANT 2 0.0000
925 ANGER 1 0.0000
926 VISION BLURRED 4 0.0000
927 ILLNESS 3 0.0000
928 INJURY 2 0.0000
929 PRODUCT ADHESION ISSUE 1 0.0000
930 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
931 MOBILITY DECREASED 2 0.0000
932 OVERDOSE 6 0.0000
933 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
934 DRUG EFFECT INCOMPLETE 1 0.0000
935 C-REACTIVE PROTEIN INCREASED 1 0.0000
936 RESPIRATORY FAILURE 2 0.0000
937 DYSURIA 1 0.0000
938 NASOPHARYNGITIS 5 0.0000
939 EYE SWELLING 1 0.0000
940 RHEUMATOID ARTHRITIS 3 0.0000
941 COLITIS 1 0.0000
942 GAIT DISTURBANCE 5 0.0000
943 PLASMA CELL MYELOMA 1 0.0000
944 DRUG DOSE OMISSION BY DEVICE 2 0.0000
945 ARTHRITIS 2 0.0000
946 ABNORMAL BEHAVIOUR 1 0.0000
947 HYPOTENSION 5 0.0000
948 SOMNOLENCE 5 0.0000
949 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
950 DYSKINESIA 1 0.0000
951 BLINDNESS 1 0.0000
952 FALL 8 0.0000
953 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
954 ABDOMINAL DISCOMFORT 4 0.0000
955 BALANCE DISORDER 2 0.0000
956 CONDITION AGGRAVATED 7 0.0000
957 PSORIASIS 3 0.0000
958 NEPHROLITHIASIS 1 0.0000
959 ARRHYTHMIA 1 0.0000
960 COMA 1 0.0000
961 PAIN IN EXTREMITY 6 0.0000
962 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
963 ABDOMINAL DISTENSION 2 0.0000
964 VOMITING 9 0.0000
965 ECZEMA 1 0.0000
966 MUSCULOSKELETAL PAIN 1 0.0000
967 DEPENDENCE 1 0.0000
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
969 HAEMATOCHEZIA 1 0.0000
970 ANAPHYLACTIC REACTION 1 0.0000
971 NECK PAIN 1 0.0000
972 CONVULSION 1 0.0000
973 EYE IRRITATION 1 0.0000
974 BONE PAIN 1 0.0000
975 CHILLS 2 0.0000
976 ILL-DEFINED DISORDER 1 0.0000
977 EXPOSURE DURING PREGNANCY 1 0.0000
978 DRY SKIN 2 0.0000
979 PRODUCT QUALITY ISSUE 2 0.0000
980 NEUTROPENIA 2 0.0000
981 INFECTION 2 0.0000
982 CONSTIPATION 3 0.0000
983 DYSGEUSIA 1 0.0000
984 HOSPITALISATION 2 0.0000
985 TREMOR 2 0.0000
986 ADVERSE DRUG REACTION 1 0.0000
987 BREAST CANCER 1 0.0000
988 DRUG INTOLERANCE 1 0.0000
989 PLATELET COUNT DECREASED 1 0.0000
990 DEATH 6 0.0000
991 DRUG DOSE OMISSION 1 0.0000